1. Home
  2. CHRO vs WNW Comparison

CHRO vs WNW Comparison

Compare CHRO & WNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHRO
  • WNW
  • Stock Information
  • Founded
  • CHRO 2002
  • WNW 2015
  • Country
  • CHRO United States
  • WNW China
  • Employees
  • CHRO N/A
  • WNW N/A
  • Industry
  • CHRO
  • WNW Catalog/Specialty Distribution
  • Sector
  • CHRO
  • WNW Consumer Discretionary
  • Exchange
  • CHRO Nasdaq
  • WNW Nasdaq
  • Market Cap
  • CHRO 8.4M
  • WNW 6.9M
  • IPO Year
  • CHRO 2024
  • WNW 2020
  • Fundamental
  • Price
  • CHRO $1.14
  • WNW $1.71
  • Analyst Decision
  • CHRO Strong Buy
  • WNW
  • Analyst Count
  • CHRO 1
  • WNW 0
  • Target Price
  • CHRO N/A
  • WNW N/A
  • AVG Volume (30 Days)
  • CHRO 83.2K
  • WNW 26.2K
  • Earning Date
  • CHRO 05-13-2025
  • WNW 07-07-2025
  • Dividend Yield
  • CHRO N/A
  • WNW N/A
  • EPS Growth
  • CHRO N/A
  • WNW N/A
  • EPS
  • CHRO N/A
  • WNW 9.06
  • Revenue
  • CHRO N/A
  • WNW $158,485.00
  • Revenue This Year
  • CHRO N/A
  • WNW N/A
  • Revenue Next Year
  • CHRO N/A
  • WNW N/A
  • P/E Ratio
  • CHRO N/A
  • WNW $0.19
  • Revenue Growth
  • CHRO N/A
  • WNW N/A
  • 52 Week Low
  • CHRO $0.45
  • WNW $0.95
  • 52 Week High
  • CHRO $3.80
  • WNW $70.00
  • Technical
  • Relative Strength Index (RSI)
  • CHRO 53.88
  • WNW 44.39
  • Support Level
  • CHRO $0.90
  • WNW $1.62
  • Resistance Level
  • CHRO $1.06
  • WNW $1.80
  • Average True Range (ATR)
  • CHRO 0.09
  • WNW 0.12
  • MACD
  • CHRO 0.03
  • WNW 0.02
  • Stochastic Oscillator
  • CHRO 95.88
  • WNW 32.62

About CHRO Chromocell Therapeutics Corporation

Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic, visceral pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.

About WNW Meiwu Technology Company Limited

Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments: Clean Food Platform; Restaurant; and Others. The company generates the majority of its revenue from Technical services.

Share on Social Networks: